T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Clinical trials for T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA trials appear
Sign up with your email to follow new studies for T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New maintenance therapy shows promise in preventing T-Cell cancer relapse after transplant
Disease control CompletedThis study tested whether a low dose of the drug chidamide, given after a donor stem cell transplant, can help prevent T-cell acute lymphoblastic leukemia or T-cell lymphoma from coming back. Forty-four patients aged 14 to 70 who were at high risk of relapse took part. The main g…
Matched conditions: T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Experimental combo aims to boost stem cell transplant for rare blood cancers
Disease control CompletedThis early-phase trial tested whether adding the drug romidepsin before and after a stem cell transplant could help control T-cell cancers like lymphoma and leukemia. Twenty-three patients received romidepsin along with standard chemotherapy, followed by a donor stem cell transpl…
Matched conditions: T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 18:59 UTC